Cardiovascular Risk in Patients Affected by Autoimmune Diseases Early Diagnosis and Treatment

Abstract

The majority of deaths developing in autoimmune diseases are caused by cardiovascular reasons, with a close relationship to this disease group. Chronic inflammation in autoimmune diseases and the inflammatory process observed in atherosclerosis have similar characteristics, and the early premature formation of atherosclerosis is one of the most important results affecting mortality in this patient group. The observation of early atherosclerosis even before clinical signs of disease means that early diagnosis and treatment choices will be the cause of stopping or slowing the progression of disease. Thus manifestations of endothelial dysfunction, development of atherosclerosis, and development of acute coronary syndrome which affect mortality and morbidity will be reduced to a minimum. In this review we aim to evaluate some tests used for early diagnosis and treatment choices in terms of the effect on disease progression in this patient group. Keywords: Premature atherosclerosis, autoimmune disease, cardiovascular disease